The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Incubator/Accelerator | Alive

About Neurotech

Neurotech creates consumer wearable electronic devices, which focus on brain-computer interface. Its flagship product NeuroBuds is a smart pair of earphones that track brain activity.

Neurotech Headquarter Location



Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Neurotech

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Neurotech is included in 3 Expert Collections, including Wearable Computing.


Wearable Computing

387 items

Wearable computing is broadly defined as companies developing devices worn or placed on the body that are equipped with technology, which can range from wearable medical devices to AR/VR headsets to GPS pet collars.


Smart Home & Consumer Electronics

1,086 items

This Collection includes companies developing smart home devices, wearables, home electronics, and other consumer electronics.


Semiconductors, Chips, and Advanced Electronics

6,021 items

Companies in this collection develop everything from microprocessors to flash memory, integrated circuits specifically for quantum computing and artificial intelligence to OLED for displays, massive production fabs to circuit design firms, and everything in between.

Latest Neurotech News

08:45 ET Paralyzed Individuals Will Soon Type With Only Their Thoughts - New BCI Platform To Be Released By Blackrock Neurotech

Nov 30, 2021

Groundbreaking Brain Computer Interface Technology Expected to Achieve Partial Restoration of Communication Function in Impaired Patients News provided by Share this article Share this article SALT LAKE CITY, Nov. 30, 2021 /PRNewswire/ --  Blackrock Neurotech , the leader in brain-computer interface (BCI) technology, has announced plans to commercialize a BCI platform in 2022, with the aim of restoring communication function in patients impaired by disabilities caused by ALS, paralysis and other spinal cord injuries. With this breakthrough technology, patients are able to create text -- simply by imagining themselves typing or writing by hand. Blackrock's brain-computer-interface (BCI) platform consists of an implant, miniaturized electronics, software, and a decoder. As a patient is thinking, electrodes implanted in the brain read the electrical firing patterns of neurons and send those signals through a bundle of five patented machine learning software decoders. The decoder algorithms have the ability to recognize and translate symbols, virtual keyboard and handwriting movements from thought patterns into communicable text. This technology could also enable patients to control a screen cursor, chair, vehicle, robotic arm or manipulator, and type speech or program shortcuts into a keyboard. The Stanford studies have demonstrated remarkable restoration of communication function, up to ten times faster than other BCI communication decoding options. The platform, along with the decoder algorithms licensed from Stanford University, has been shown to enable much faster rates of thought-to-text typing and with higher accuracy than previously demonstrated by other BCI applications to date. The decoders enable typing speeds of up to 90 characters per minute, with 94% thought-to-text live accuracy and up to 99% accuracy with post-processing auto-correction work. The immediate goals of this initiative are to demonstrate that patients experience increased independence, improved quality of life, and the ability to return to the workforce with their use of the platform. "This is the first step towards providing people with limited communication ability the opportunity to communicate more effectively," said Florian Solzbacher, Chairman and President of Blackrock Neurotech. "The Stanford studies have demonstrated remarkable restoration of communication function, up to ten times faster than other BCI communication decoding options. The eventual goal is to enable communication functions on par with that of an able-bodied person. The progress is truly incredible." Blackrock is committed to make the technology available to the broader neuroscience community for research, and provide as many patients as possible with access to and use of this BCI. With the aim of commercialization in 2022, Blackrock will be the first-in-market to distribute this complete BCI system. "We are thrilled that commercialization is now possible. Not only is there sufficient data to support the first applications, but more importantly, patients are asking for the product," says Marcus Gerhardt, CEO of Blackrock Neurotech. "We hope this device is just the first of many advancements in helping patients regain independence and overcome limitations posed by their disability." About Blackrock Neurotech Blackrock Neurotech, formerly known as Blackrock Microsystems, is dedicated to the clinical translation of brain-computer interface (BCI) technology. Blackrock, founded in 2008, is the world's leading platform company for BCI technology and the development of implantable solutions that improve human lives. Blackrock's precision electrode technology is at the core of many worldwide innovations in BCI, enabling dozens of early users (known as "BCI Pioneers") to SeeAgain, HearAgain, MoveAgain, and more. For more information, visit . Press Contact:

Neurotech Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Neurotech Rank

  • Where is Neurotech's headquarters?

    Neurotech's headquarters is located at Kerala.

  • What is Neurotech's latest funding round?

    Neurotech's latest funding round is Incubator/Accelerator.

  • Who are the investors of Neurotech?

    Investors of Neurotech include Bosch DNA.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.